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Canine rabies, responsible for most human rabies deaths, is a serious global public health concern. This zoonosis is entirely
preventable, but by focusing solely upon rabies prevention in humans, this “incurable wound” persists at high costs. Although
preventing human deaths through canine rabies elimination is feasible, dog rabies control is often neglected, because dogs are not
considered typical economic commodities by the animal health sector. Here, we demonstrate that the responsibility of managing
rabies falls upon multiple sectors, that a truly integrated approach is the key to rabies elimination, and that considerable progress
has been made to this effect. Achievements include the construction of global rabies networks and organizational partnerships;
development of road maps, operational toolkits, and a blueprint for rabies prevention and control; and opportunities for scaling
up and replication of successful programs. Progress must continue towards overcoming the remaining challenges preventing the
ultimate goal of rabies elimination.
1. Introduction
Today, RNA viruses play an increasingly important role
in emerging human diseases throughout the world [1–
5]. One of the main reasons for this is their ability to
evolve rapidly, adapting to new species of hosts and thus
to expand their range [6, 7], including humans (i.e., new
zoonotic diseases). Social and environmental changes also
contribute to providing new ecological niches and promoting
the rapid selection of novel virus variants [8–10]. This group
of viruses includes the causative agents of rabies. As with
most generalist agents of a zoonotic nature, rabies is a
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very complex disease, in part because of its wide global
distribution, the diverse number of virus variants and host
species, its extremely high case fatality rate, and for its
existence at the border between animal and human health.
Rabies occurs across Africa, the Americas, Australia, and
eastern Europe and Asia, from polar regions to temperate
latitudes, and is endemic within tropical areas. Recognized
etiological agents consist of an expanding range of species
(previously genotypes) of negative-strand RNA viruses of
the Lyssavirus genus [11]. Although susceptible natural
hosts include all mammals, this zoonosis is perpetuated
by domestic and wild carnivores, and by many species of
bats, which all act as reservoirs for the eleven proposed
Lyssavirus species and for emerging variants within species
[12]. Humans are infected after being exposed to virus laden
saliva or tissue from a rabid animal, usually through bites
into open wounds or contamination of mucous membranes.
There is no treatment and rabies almost always leads to death
after the onset of clinical symptoms. A plethora of viral
species and variants maintained by a diversity of hosts with
potential for cross-species and cross-order transfers pose
a formidable challenge to a strict concept of true disease
eradication [13]. However, in any one geographic area, rabies
virus (genotype/serotype/species 1), which is responsible for
classical rabies and themost important cause of human cases,
is typically maintained within a single terrestrial animal
reservoir. Elimination of rabies virus variants is, therefore,
a more realistic prospect.
The ultimate objective of controlling rabies is the pre-
vention of human deaths. Human rabies mortality can be
reduced through ensuring administration of vaccine and
immunoglobulin (postexposure prophylaxis, PEP), follow-
ing extensive washing of the wound, to all bite victims from
infected animals. However, these life-saving biologics are
often not accessible or affordable to the populations most
at risk [14]. Furthermore, interventions focusing solely on
rabies prevention in humans have no impacts on reducing
infection in maintenance hosts, hence on achieving rabies
elimination from an area—the so-called “incurable wound.”
For centuries, rabies control in reservoir hosts has consti-
tuted an essential measure to decrease the burden of human
mortality. Effective vaccines for animals are available, and
most developed countries have eliminated canine rabies [15–
17], responsible for the vast majority (99.9%) of all human
cases [18], by preventing the disease in dogs. However, lack
of effective canine rabies prevention and control programs
in poorly resourced countries continues to cause tens of
thousands of human deaths every year [18]. In canine rabies
endemic countries, rabies is a recurrent public health issue
and also represents a threat to rabies-free areas through
the movement of infected dogs—as was the case in Bali,
where rabies was introduced recently [19, 20]. Despite the
availability of modern and efficient prophylaxis tools for
humans and animals, on average, rabies still kills one person
every 10 minutes, with the highest burden of mortality in
Africa and Asia and most of the deaths occurring in children
less than 15 years old [18].
Ineffective rabies prevention and control across most of
the developing world has been driven by a lack of awareness
about disease impacts and institutionalized attitudes about
where the responsibility for development and enforcement
of rabies control and prevention programs resides. From
a public health perspective, rabies remains a “neglected”
zoonosis largely because it occurs in communities suffering
from poverty and inequitable human and animal health care
[21]. Rabies predominantly affects the poorest segments of
the population, living in remote, rural areas with insufficient
access to life-saving interventions and the services to deliver
them. These communities have little political voice and,
therefore, limited impact on health policy making. As a
consequence, rabies ranks low within national and interna-
tional agendas, in spite of being present in more than 150
countries/territories and representing a public health threat
to more than 3 billion people in Asia and Africa alone [18].
In addition, from an animal health perspective, the
species mostly involved in rabies maintenance and transmis-
sion to humans in rabies-endemic areas, the domestic dog, is
often neglected by veterinary services serving the agricultural
sector and/or the public health sector. In Asia, Africa, and
Latin America, a substantial proportion of the dog popula-
tion is unrestricted or semirestricted (stray), neither under
direct control of their owners nor confined by a physical
barrier [22–28]. This term encompasses both owned and
unowned roaming dogs and does not distinguish whether the
dog has an “owner” or “guardian”. Indeed, inmany countries,
the majority of dogs defined as roaming are owned, but are
allowed to roam on public property for all or part of the day.
These dogs fall into an institutional vacuum. They are not
included in any conventional health care system as compared
to other species recognized as disease vectors (for example,
insect vectors of malaria or dengue) that are controlled as
part of public health control programs. Dogs are neither
a species that the agricultural sector/veterinary services are
inclined to take full responsibility for as, unlike livestock
species, they are not a recognized economic commodity.
Only fully owned and restricted dogs, which are a minority
in countries where canine rabies is prevalent, are generally
of interest, but mostly to private veterinary practitioners. As
a consequence, in many rabies-affected countries, veterinary
services and private veterinarians do not have the will nor
the desire to prioritize and allocate the resources required to
control a disease that is primarily seen as a public health issue
with limited impact on production animal health or small
animal private practice.
When we consider where the responsibility for rabies
control resides, the issue becomes increasingly complex.
Given the cosmopolitan nature of rabies, and the widely
recognized global burden of mortality among humans,
domestic animals, and wildlife [13, 29], no one institution,
agency, or country can bear the sole responsibility for
effective rabies prevention and control. Rather, rabies is a
“transboundary” disease, and basic intersectoral cooperation
at any level requires a breadth of expertise, not residing in one
single health ministry, agricultural department, academic
endeavor, or private enterprise. In a true “One Health”
context [30], a wide variety of basic disciplines are necessary
for a comprehensive rabies elimination program, including
animal control and welfare, diagnostic, ecology, economy,
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education, epidemiology, health communication, anthropol-
ogy, human and animal health services, virology, and wildlife
biology. To be truly efficient, such multifunctional programs
need to benefit from and begin with the essential support and
commitment of country-based human and animal health
authorities.
To this effect, significant milestones have been achieved
motivated by the compelling need for alleviating the burden
of rabies worldwide. Progress has beenmade towards uniting
global expertise to promote a global campaign against
rabies, bridging the gap between research-driven knowledge
on rabies and its control and practical action towards
its elimination, and creating a model that will stimulate
further veterinary efforts in global health research and
practice towards the control of zoonotic pathogens. Here we
illustrate these achievements, including (1) global, “political”
initiatives; (2) global, “applied” initiatives; and (3) regional,
local, yet scalable and replicable initiatives. We conclude by
discussing the challenges and future directions for additional
initiatives on a global basis.
2. Global Partnerships in Rabies
Prevention and Control
2.1. Building Global Partnerships. The building of public
private partnerships is proving to be one of the most effective
global strategies to address the needs of disadvantaged
populations living in the midst of neglected diseases [31]
that are no longer considered to be a priority in industrial-
ized nations [32–34]. If established in a balanced manner,
public-private partnerships can bring together the power,
resources, and experience from both the industrialized and
the developing world to create synergies, define priorities,
and find solutions. There are many examples of successful
public private partnerships that have pooled their resources
and have coordinated global strategies to increase the
availability of scarce and expensive medical interventions
for those that need them most. For example, the Global
Alliance to Eliminate Lymphatic Filariasis (GAELF) consists
of a partnership between academic and research institu-
tions, advocacy and resource mobilization partners, coun-
try representatives, international development agencies and
foundations, international organizations, nongovernmental
development organizations, and private sector companies
[35]. This group retains a “light governance structure” that
provides the flexibility to focus on specific needs at regional
and national levels [35].
Several attempts at regional or international partnerships
in rabies prevention and control have occurred throughout
the 20th century. For example, once oral vaccination of
wildlife became a reality during the 1980s, the World Health
Organization (WHO) held multiple consultations involving
its global network of WHO Collaborating Centers for
Reference and Research on Rabies for an organized approach
towards red fox rabies elimination in Western Europe. The
breadth and longevity of several other partnerships, such
as the Rabies in the Americas Association, Latin-America
National Rabies Directors Network (REDIPRA), Southern
and Eastern Africa Rabies Group (SEARG), Rabies in Asia
Foundation (RIA), Asia Rabies Expert Bureau (AREB),
Africa Rabies Expert Bureau (AFROREB), and the recently
created Middle East and Central Eastern Europe Rabies
Expert Bureau (MEEREB), all demonstrate the utility of
coalitions in successful information flow and regional health
promotion in bringing support to local scientific and public
health communities worldwide. As consistently observed
by all existing rabies networks, basic education of people
exposed to the risk of infection, the appropriate training
of human and animal health professionals, and necessary
advocacy by local health decision makers, are major mile-
stones towards global rabies control. The North American
Rabies Management Team is another recent example of
professionals in Canada, Mexico, and the United States
working together, sharing surveillance data, prioritizing
applied research needs, and cooperating across the continent,
in training and technology transfer, which allows the imple-
mentation of human and animal rabies control programs,
achieving a drastic decrease of rabies cases in this region of
the world.
The establishment of these partnerships has been of crit-
ical importance in raising the profile of rabies at the regional
level. However, a much wider (global) approach is needed in
strategies aimed at rabies elimination, recognizing that the
threat of rabies is evident on every continent throughout
the world excluding Antarctica, disregards national borders
and that disparity in knowledge and resource capacity should
no longer be a reason for inequitable health. In the 21st
century, the formation of the Global Alliance for Rabies
Control (GARC) and the Partners for Rabies Prevention
(PRP) groups perhaps best epitomizes this shift from a
regional to a global approach and the modern concept of
a global health fellowship [36]. Although these coalitions
specifically focus on global rabies control and prevention,
they have been established based on a number of broad
principles relevant to health issues of zoonotic nature and
aimed at addressing the needs of populations suffering
from inequitable human and animal health systems. These
elements include the following: (1) creating a working group
integrating all disciplines/institutions relevant to a compre-
hensive approach to the control and eventual elimination of a
given zoonosis. The inclusion of international organizations
is of particular importance, especially as societal and political
considerations determine the success of disease elimination
[37]; (2) identifying specific gaps concerning biological and
technical feasibility, costs and benefits, and societal and
political considerations [37], which prevent the control,
prevention, and eventual elimination of a given zoonosis; (3)
working together to agree upon the most effective strategies
to address these gaps; (4) identifying the partners within the
partnership that can provide the expertise to deal with these
gaps; (5) establishing programs to practically deal with these
gaps; and (6) demonstrating success by delivering results
with respect to these programs.
GARC is the first global nongovernmental organization
focusing specifically on increasing awareness and advocacy
for rabies prevention and control by supporting community-
led interventions. Using the GAELF as an example, the
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PRP was established in 2008 and is comprised of an
informal group of stakeholders working in the field of
rabies prevention and control. This is the first time that
a working group consisting of all key stakeholders in the
field of rabies have joined to find workable solutions to
rabies control, including timelines and deliverables. The
PRP includes representatives frommajor international health
organizations (WHO/Pan American Health Organization
(PAHO), Food and Agriculture Organization (FAO), World
Organization for Animal Health (OIE), European Commis-
sion (EC)), nongovernmental organizations includingGARC
and animal welfare organizations, representatives from the
human and animal healthcare industry, and global health
institutions, such as WHO Collaborating Centers for Rabies
Research, and academic institutions working on new rabies
prevention and control tools. The individuals in PRP are
unpaid volunteers, comprised of the essential disciplines
needed towards a common cause of advocacy, action, and
research, in an international context. Together, members of
the PRP continue to evaluate the global situation of rabies to
find feasible, achievable solutions. The PRP thus provides a
foundation by which partners can combine their resources,
including expertise and experience, communications net-
works and outreach, and data and educational material
to improve access to rabies prevention and control tools
(Table 1).
2.2. Developing and Implementing Programs with Partners.
Public-private partnerships, such as the GAELF and PRP,
provide a rich environment for brainstorming and opti-
mizing the skills and knowledge required to generate new
ideas, create realistic milestones and deliverables, and build
novel systems around which global health strategies can be
agreed upon. In the field of rabies, the PRP focuses on
increasing global attention on rabies, enhancing educational
awareness on all levels of society, and providing new tools
for both poorly resourced and industrialized nations to
improve access to rabies prevention and control, particu-
larly for those living at greatest risk. Regarding increasing
advocacy and awareness on local, national, and international
levels, a “road map for rabies prevention and control” was
initially developed including short-, medium- and long-
term achievable goals. The network of the PRP agreed
to utilize their resources to increase educational awareness
for rabies prevention and to build a global network of
rabies experts by supporting the World Rabies Day initiative,
launched in 2007 [38–42]. One example of the successful
collaboration provided by the PRP includes the coordinated
efforts of the GARC, Centers for Disease Control and
Prevention (CDC) in the US, the Universities of Washington
and Pretoria, and FAO to distribute over 52,000 rabies
awareness posters to 21 countries in Africa. World Rabies
Day, observed annually on September 28th, the anniversary
of the death of Louis Pasteur, has provided the vehicle
by which rabies educational material can be transmitted
through the global network set up through the PRP to
reach more than 150 countries. Since its inception, life-
saving rabies prevention messages have been sent to more
than 150 million people across the globe. The response
of communities worldwide since the World Rabies Day
inaugural campaign in 2007 is evidence that people living in
rabies endemic areas have a desire for relevant educational
material and are willing to support community programs
aimed at increasing awareness about rabies prevention and
control [40, 43].
The PRP next combined their knowledge, efforts, and
resources to define specific strategies that would enable
canine-rabies endemic countries to design their own national
programs for preventing human rabies. Despite the avail-
ability of several guidelines and publications on various
aspects of controlling rabies in dogs and preventing rabies in
humans, it was realized that there was no integrated standard
operating procedure or “Blueprint” bringing together all
necessary aspects for a “One Health” approach to controlling
rabies. Rabies is a zoonotic disease and, in order for interven-
tions to be successful, control programs must incorporate an
integrated, or One Health, approach including human and
animal public health principles, diagnostics and surveillance,
education and advocacy, anthropology, social mobilization
and community outreach, research and development, and
program implementation and evaluation as well as funding
options. The need for such comprehensive strategies has
been clearly identified following the successful adoption of
this approach in Latin America leading to dramatic impacts
on human and animal rabies cases [44]. The PRP was able
to draw on global expertise to incorporate all of these aspects
into a Blueprint for rabies prevention and control which is
currently available online. [45]. As a next step, the PRP is
focusing on combining their efforts to re-evaluate the global
burden of rabies in order to establish the cost effectiveness of
intervention strategies.
Operational activities related to public-private part-
nerships are a challenge because strong partners may be
restricted by their own institutions or companies as to their
level of involvement and they often do not have the time to
dedicate to the administering of required activities to reach
agreed upon goals. However, one of the major strengths of
a public private partnership is the ability to establish new
approaches to overcome administrative barriers. The GARC
acts as a secretariat for the PRP and is dedicated to bringing
all partners and stakeholders together in a timely manner,
without bias, and ensuring that operational activities run
smoothly.
Other important considerations involved in setting up
public private partnerships include establishing the correct
balance between the variety of players that are involved
as each may have different and often competing interests.
If the correct balance is not initially established or is not
continuously maintained, there is a potential to lose focus
and the most urgent problems may not be addressed. The
PRP has resolved these issues by setting up the organization
in a similar manner as the GAELF [35]. The PRP maintains
a light governance structure, meeting biannually to discuss
global issues regarding rabies prevention and control, iden-
tify gaps and how best to address them, and concentrating
on finding workable solutions that will benefit all of society
(Table 1).
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3. How Can Canine Rabies Be Eliminated?
3.1. Components of a Canine Rabies Elimination Program.
Perhaps the most important insight generated from decades
of epidemiological and operational research on rabies is that
the elimination of both canine and human rabies is a feasible
objective in rabies endemic areas of the less developed world
[12, 29, 44, 46–50]. We now have a very clear understanding
of what constitutes the critical components of a successful
rabies elimination program, and we also recognize that
a fully integrated approach is critical for achieving this
significant goal. One key scientific finding is that where rabies
epidemiology is driven by cycles in domestic dogs, as in
most of Africa, Asia, and Latin America, well-implemented
and sustained rabies vaccination and control programs that
target this species will lead to elimination of canine rabies in
most areas [12]. Thus, a radical “paradigm shift” in strategic
planning and implementation activities is required by the
many countries focusing solely on human rabies prophylaxis
to prevent human deaths. Dog rabies control should be the
focus of efforts and resources also in areas where (occasional)
rabies cases are detected in wildlife, since elimination of
rabies in dogs should lead to the disappearance of the disease
in all other species. Control efforts targeted at wildlife should
only be considered where independent transmission cycles
are detected in species other than dogs. Once canine rabies
has been eliminated, rabies control strategies should aim at
maintaining freedom from the disease. A sustainable rabies
control and prevention program, therefore, consists of two
essential components, an “attack/elimination” component
and a “maintenance” component.
Although the implementation of each of these two phases
requires specific techniques, a number of “preparatory”
steps are essential to both components. These include (1)
increasing awareness about the local and global impacts of
rabies as well as its burden on public health budgets, and
establishing specific roles and responsibilities and cooper-
ation amongst all parties involved in rabies control and
prevention activities; (2) building capacity and allocating
resources to laboratory-based surveillance, and control and
prevention operations, including training of relevant profes-
sionals; (3) establishing a legislative framework relevant to
rabies control and prevention; (4) ensuring engagement of
local communities through raising awareness and education;
and (5) obtaining information on the size and accessibility
of the dog population to define the best strategy for canine
rabies control compatible with local circumstances.
The “attack/elimination” component combines activities
aiming at preventing the occurrence of human rabies by
reducing virus transmission in the dog population. These
include: (1) mass vaccination of the maintenance dog
population, (2) management of the dog population, and
(3) improved access to wound cleaning necessities, human
rabies biologics, and information on available bite centers or
emergency rooms. Throughout the elimination component,
continuous epidemiological surveillance is essential to mon-
itor the effectiveness of intervention in animal and human
populations and to prevent overuse of human biologics.
Mass dog vaccination has long been recognized as the
mainstay of successful dog rabies control and eventual elim-
ination [12, 48]. In the most affected continents, Africa and
Asia, generally characterized by very dense dog populations,
adequate levels of coverage, of at least 70% [12, 51], as well
as sustained and frequent (usually annual) campaigns are
essential for effective control aimed at achieving a “rabies-
free” status. Since dogs are often unrestrained and with-
out any apparent evidence of ownership, local authorities
often view costly oral vaccination of free-roaming dogs as
the only solution to the rabies problem in the reservoir
population. However, the vast majority of domestic dog
populations have affiliations to households/communities
and are, therefore, accessible for central-point parenteral
vaccination, considered the most cost-effective strategy [29,
52–55]. Participation in dog vaccination campaigns can also
be increased by improved engagement of local communities
through education and awareness, as discussed below, and
delivery of “primary animal health care” against common
infections (mange and internal parasites) to dogs brought
to vaccination stations as in KwaZulu-Natal [56]. In some
circumstances (e.g., very aggressive or truly unowned dogs,
and dispersed communities) more intensive (i.e., house-to-
house) efforts [55] or alternative (oral) delivery strategies
[57, 58] may, however, be required. In some circumstances,
the effectiveness of mass dog vaccination campaigns can
be increased through management of the dog population.
Needs for this are determined at the start of the program
through ecological surveys, generally conducted as part of
the preparatory phase. A combination of approaches are
available for dog population management programs: pro-
motion of responsible dog ownership through community
education and legislative measures (mandatory dog registra-
tion and identification, tie-up orders, abandonment legisla-
tion, etc.); reproduction control [59]; temporary/permanent
removal of dogs (shelters, foster homes, capture and release,
euthanasia); and habitat control [60]. Elimination of dogs
should be restricted to suspect rabid dogs, unvaccinated
contact dogs, and dogs considered unsuitable for rehoming
or release at the point of capture, and should always be
implemented in conjunction with other approaches [60].
Reducing human rabies incidence through correct uti-
lization of human biologics, including preventive immuniza-
tion of categories at risk, and wound care (through thorough
washing of the wound with water and soap) and prophylaxis
(vaccine and rabies immune globulin, RIG, when required)
of individuals exposed to suspect rabid animals, is an essen-
tial component of the rabies elimination phase. Awareness
about prevention behaviors among community members,
particularly children, is critical and can be increased through
appropriate communication channels, as illustrated below.
While the integration of dog rabies control and human
rabies prevention approaches is important at the start of
the program to reduce animal and human rabies incidence,
progressive declines of canine rabies should ultimately result
in reduced demand for human biologics [61].
Once freedom from canine rabies [12] has been achieved
through the attack/elimination phase, the implementation
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of a “maintenance” phase is required to prevent reintro-
ductions of disease and to ensure a continuous rabies-
free status. This component involves the maintenance of
features established in previous phases including continual
high political commitment and intersectoral cooperation,
surveillance networks to uncover potential new cases or
infected areas, regulations for in-country animal movements
and animal trade, capacity for dog vaccination (e.g., mainte-
nance/containment/emergency vaccination), policies on the
judicious use of human rabies biologics, and educational
channels linking government officials and local communi-
ties. Themaintenance phase also comprises specific activities.
An assessment of the rabies situation in neighboring areas
is important, ideally followed by the establishment of
rabies control and prevention efforts in these jurisdictions
through close liaison and effective collaborations involving
key stakeholders. Careful consideration also needs to be
given to building sustainability in established programs to
maintain freedom from rabies in the long term. When
national rabies management efforts are developed as multi-
sectoral programs, this could be achieved through integrated
financial mechanisms across relevant sectors and parties,
with costs and benefits shared across ministries.
Clearly, much progress has been made in the develop-
ment of tools and strategies required for effective rabies
prevention and control. The process of translating research-
driven interventions into better health outcomes for the
populations living in rabies-endemic settings is, however,
long and difficult. Yet, one recent achievement in this
direction is to have gathered and synthesized all current
scientific knowledge and available information on rabies
prevention and control into the recently launched “Rabies
Blueprint” [45], an easy to use operational tool kit, which
has the potential to contribute to evidence-based policies and
action towards rabies elimination.
3.2. The Role of Global Health Communications. For the
successful accomplishment of a canine rabies elimination
program, the importance of engaging critical players in
rabies prevention and control, that is, national and interna-
tional policy makers as well as communities at risk, cannot
be overstated. A higher level of awareness is a key to effective
public and animal health policy and action at all levels, prior-
itization of rabies in national and international budgets, and
increased intersectoral dialogue, hence collaborative rabies
prevention and control initiatives. Enhanced awareness on
rabies is also essential in preventing and ensuring adequate
management of human exposures [12, 62, 63], engaging
personnel and communities in rabies prevention and control
efforts, and increasing reporting of cases [13].
To this effect, the involvement of global health com-
munications (the study and use of methods to inform and
influence individual and community decisions that enhance
health) has gained increasing prominence in rabies elimina-
tion strategies worldwide. The World Rabies Day initiative is
an example of the global impact that health communications
can have on rabies prevention and control efforts [38–42].
Utilization of fundamental and innovative communication
techniques as part of this initiative has increased awareness
globally, enabled life-saving information to be communi-
cated across the world instantaneously, galvanized support,
empowered stakeholders at every level, and re-ignited rabies
control efforts in countries that had previously abandoned
national programs. The establishment of this global rabies
network is not the only achievement of including health
communications in the global campaign against rabies.
Using modern health communications research [64, 65], a
comprehensive 8-step rabies communications plan, adapt-
able to the cultural, political, and behavioral needs of any
location, has been developed for incorporation into a canine
rabies elimination program [45].
Since rabies epidemiology and the behavioral or cultural
beliefs of the individuals most at risk will vary across local-
ities, the first step of the communications plan is to identify
the important points from an epidemiologic assessment as
well as a comprehensive list of potential issues, challenges,
and barriers to change that may affect the communication
outreach. Challenges may be behavioral (e.g., beliefs on
the use of medicine or vaccines), cultural (e.g., perceptions
on dogs or other mammalian species), demographic (e.g.,
economic implications), or physical (e.g., access to healthcare
or clean water). Another important aspect is to define the
purpose of the communication, including identifying goals
and objectives which should be adapted towards national
needs. In addition, any outreach should be targeted to
specific audiences, who can be segmented according to those
most at risk, the primary audience (e.g., children and young
boys, who inmany areas take care of dogs), and influencers of
the primary audience (e.g., healthcare providers, community
leaders, and policy makers).
Once draft messages are developed, they should be
tested with the target audience. Audience segmentation and
message testing will ensure thatmessages resonate with target
populations and can improve uptake of prevention behaviors
[66]. In launching a communications campaign, choosing
appropriate media channels and determining the best timing
for release are also critical. There are numerous ways to
disseminate rabies educational messages, and benefits and
limitations to each of the channels [67]. After implementing
any communications effort, evaluating its impact will help
inform and improve future educational outreach, although
funding limitations may discourage some localities from
undertaking this task. Nonetheless, there are several ways in
which rabies programs can be evaluated [68], and options
exist for evaluating communication efforts regardless of
funding, such as process evaluation and outcome evaluation
[45].
4. Scalable Pilot Projects
The need for integrated approaches towards human rabies
prevention, which incorporate disease control in the canine
reservoir, has been widely recognized by major international
health organizations. For such strategies to become truly
applicable and universally accepted, successful pilot projects
are essential to demonstrate the feasibility of canine rabies
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control/elimination and direct benefits for human health.
Such projects have the potential to reduce rabies incidence
locally, and act as catalysts for encouraging larger-scale
or national programs, engaging other areas/countries in
similar initiatives, and attracting major international funding
support. Building upon the success recognized in Latin
America [44], a number of pilot programs have been
established recently across Asia and Africa, as described.
4.1. Colombo. A “Humane and Sustainable Dog Population
and Management” program has been initiated in Colombo
(Sri Lanka) starting in 2007, including the establishment
of a formal partnership between three primary partners:
Colombo Municipal Council (CMC), Blue Paw Trust (BPT)
and theWorld Society for the Protection of Animals (WSPA).
The first phase of the program is planned for 2008–2012.
In a second phase (after 2012), CMC will assume primary
financial responsibility from WSPA. The current humane
program is an evolution of the elimination and pound
system of rabies control and dog population management
that existed prior to 2007. Key components of the program
include mass vaccination and targeted sterilization over
the entire spectrum of the dog population; education of
children and adults in bite prevention, rabies awareness, and
responsible dog ownership; development of “Dog Managed
Zones”; and training of CMC staff in relevant skills, including
humane dog handling, recognizing dog behavioral signs,
delivering responsible ownership messages to communities,
and surgical neutering. Increased vaccination and dog man-
agement efforts resulting from existing national programs
as well as the newly implemented pilot project have led
to a considerable reduction in dog rabies cases [69, 70].
In addition, the combined education program on bite
prevention, rabies awareness, and responsible dog ownership
has led to greater primary knowledge and its retention.
Specifically, 86% of primary school children and 90% of
secondary school children gained the required knowledge
immediately after education sessions, with 85% of primary
and 78% of secondary school children maintaining this same
level of knowledge after 6 months [70].
4.2. Bali. The recent introduction of dog rabies in Bali,
Indonesia (with >3.5 million people) during 2008 resulted
in a major outbreak, which has killed more than 100 humans
with a total of 31,000 dog bite injuries and administration
of PEP to 28,000 people since November 2008 [19, 20]. The
island had previously been “rabies-free,” and the local veteri-
nary authorities had little or no experience in rabies control.
First attempts at vaccination and dog movement restrictions
failed to stop rabies spread from the initial outbreak on the
Bukit peninsular. Following this outbreak, the government
began to cull dogs using strychnine, increasing the activity
in late 2009. Reasons for this action were that (1) the Bali
Animal Husbandry Agency did not believe that reaching
sufficient vaccination coverage was possible; (2) vaccination
campaigns were inadequate largely because of difficulties in
handling many of the dogs, a result in part of the local dog
owning culture (hands-off), which is common in most of
Indonesia; and (3) the issue of roaming (stray or outside)
dogs caused a distraction, leading to the diversion of limited
resources and attention away from effective rabies control via
dog vaccination towards attempts to reduce dog populations.
To assist the government in developing a coordinated
and effective rabies control program, towards the end of
2009, WSPA started collaborating with local organizations,
the Yayasan Bali Animal Welfare Association (BAWA) and
the Bali Street Dog Fund Australia, to develop a pilot mass
vaccination project in Gianyar, one of Bali’s nine regencies.
By the end of May 2010, 44,776 dogs had been vaccinated
in 537 banjars (banjar = small subvillage of 100–200 dogs
approximately), with an estimated 87% vaccination coverage
obtained [69]. Although the average coverage at the end
of the first one-day vaccination campaign was 81%, in 81
of the 537 banjars (15%) the coverage was estimated to
be below 70%, and hence a second vaccination campaign
was launched. In all cases, second campaigns resulted in
over 70% coverage. While the rate of human rabies deaths
has increased recently, with all nine regencies now infected,
reflecting the continuation of the epizootic, confirmed
human fatalities in Gianyar have been limited to one case
since the start of the pilot mass vaccination project [71,
72]. These preliminary results of the pilot program confirm
that mass vaccination of the reservoir species is a more
effective and humane method of rabies control than culling.
In the week before World Rabies Day 2010, the Balinese
government signed an agreement with the BAWA to extend
the mass vaccination project to Bali’s remaining regencies,
with cooperation and collaboration of the provincial and
regency governments and utilizing a large donation of animal
rabies vaccines funded by AusAID and procured by WHO.
4.3. Bohol. Another example of a pilot program for the
prevention of human rabies through reservoir control is
the Bohol Rabies Program on the provincial island of
Bohol with a population of 1.2 million. This program has
been anchored on community-based initiatives, focusing
on collaboration with the local government, empowerment
of local communities to design, implement, and manage
their own rabies control programs in accordance with the
national rabies program, education of key target audiences
(i.e., school children), and elimination of rabies in dogs. The
Bohol project has been supported by the GARC and the
provincial government, and has also been funded through
other cost-sharing activities from the national government,
provincial, municipal, and village or barangay local govern-
ment units, dog owners, and other nongovernmental part-
ners. Since its inception in 2007, the project has mobilized
around 15,000 people including local government officers,
animal and human health workers, school teachers, village
leaders, and volunteers (village-based “rabies watchers”);
introduced rabies education into school curricula in all
public elementary schools on the island (reaching >182,000
children); generated $105,740 through community fund
schemes to support dog rabies control programs; reduced
the dog population by 24% (including the removal of
unregistered, unowned, unmanageable, or unclaimed dogs
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according to the National Animal Welfare Act, and those
that had either died of other causes or had been exported
from the island); registered 53,692 and vaccinated 53,739
(70%) dogs; castrated 34.5% of male dogs; and increased
accessibility of PEP (773 in 2005, 1,497 in 2006, 2,906 in
2007, 2,287 in 2008, and 2,276 in 2009) [73]. While the
effectiveness of mass dog vaccinations has been enhanced
by dog population management in this case, measures are
currently being taken to reduce the need to further eliminate
dogs and improve animal welfare standards when removal
is required. Measurable positive impacts of the program
include increased awareness and enhanced animal and
human health. Specifically, community awareness surveys
revealed that >94% of local people heard about rabies, >61%
had knowledge about rabies transmission, and >82% was
aware and supportive of the Bohol Rabies Program [73].
Additionally, as of October 2010, Bohol will have had no
reported rabies deaths in humans or in animals for two full
years.
4.4. Rabies Elimination Demonstration Projects. Rabies
projects have also been supported by major international
funding agencies to serve as a “hands-on” example to
demonstrate the feasibility and effectiveness of an ideal “One
Health” approach to human rabies prevention. Through
the support of the Bill and Melinda Gates Foundation and
coordination by WHO, three large-scale rabies elimination
demonstration projects, based on mass vaccination of
domestic dogs, have been implemented in Africa and Asia
(KwaZulu Natal in South Africa, Tanzania, and Philippines)
containing over 33 million people and aiming at vaccinating
3 million dogs [74].
The KwaZulu Natal site (population of 9,500,000 inhabi-
tants) extends from the international borders with Swaziland
andMozambique in the north, to the province of the Eastern
Cape in the south, while inland it is bound by the provinces
of the Free State and Mpumalanga, and by the Kingdom
of Lesotho. The project aims at vaccinating about 700,000
dogs regularly during the project duration. The effective
veterinary structure involved in rabies control measures and,
more recently, the stronger commitment from provincial
authorities alleviated many of the logistical, financial, and
managerial difficulties in the implementation and main-
tenance of successful dog vaccination strategies and have
been critical factors in successful implementation to date.
Since 2009, the program has already achieved reductions
in dog and human rabies prevalence through mass mobile
vaccination campaigns, as well as targeted sterilization and
dog management programs [56]. The program has also led
to notable improvements in the delivery of PEP, with fewer
human deaths recorded at present.
In the Philippines, the project includes only the Visayas
group of islands covering 25% of the total number of animal
rabies cases, 28% of the total cases of human rabies, and
27% of animal bites in the entire country based on the 2006
annual rabies report. Three of the 17 administrative regions
of the country, 16 provinces and 31 cities of the country’s 82
provinces, and 117 cities are, therefore, included. The project
serves almost 19% of the country’s human population (with
17million inhabitants in the area) and an estimated 2million
dogs.
The project site in south-east Tanzania includes Dar
es Salaam, Lindi, Mtwara, Morogoro, and Pwani Regions,
comprising 24 districts, 459 wards, with approximately
6,200,000 people and 400,000 dogs. Infrastructure is being
developed, and implementation of prevention and control
programs has been initiated in Dar es Salaam and Morogoro
regions.
Although the ultimate goal of these programs is to
achieve local prevention of human rabies through the
elimination of canine rabies from all sites within a 5-year
period, the overall project is designed to be extended into
neighboring regions and countries in an effort to achieve
regional and international success towards broader canine
rabies elimination.
5. Challenges and Future Direction
There is no doubt that, from a veterinary and medical
standpoint, considerable progress has occurred towards
rabies prevention and control. Despite this achievement,
obstacles remain that have impeded successful control. Here,
we discuss these challenges, and suggest future strategies to
overcome them.
5.1. Global Burden of Rabies. One of the most important
challenges is to reverse the cycle of neglect, which has created
a low priority to rabies and its control in many poorly
resourced countries. Global advocacy and enhanced aware-
ness of the disease burden among national and international
policy makers are essential to improve rabies prevention
and control activities. Data on disability-adjusted life year
(DALY) scores and economic burden models are required to
compare a given condition in relation to other public health
issues, although these elements are not the only criteria on
which priorities are defined. Evidence-based estimates of the
burden of rabies have been developed for Africa and Asia, as
well as specific countries, such as Tanzania and Cambodia
[18, 75, 76], which indicate that canine rabies impacts
human and animal health substantially, as well as local
and national economies and wildlife conservation [29]. The
global burden of rabies, including amore accurate evaluation
of the global cost of postexposure prophylaxis as well as mass
dog vaccination strategies, needs to be further documented
and brought into the spotlight, particularly to the attention
of national policy makers in rabies-affected countries and
to the international health community. Therefore, there
is an urgent need to gain a better sense of the burden
of animal and human rabies in any given country. Given
that poor surveillance and underreporting have dramatically
contributed to a lack of data on disease impacts [77], a
focus on strengthening national capacity to better diagnose
rabies and investigate human cases and animal outbreaks is
essential for effective disease surveillance and amore accurate
burden assessment.
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5.2. Veterinary Services. Clearly, rabies is a primary public
health issue, but is not without agricultural impacts. Major
obstacles are the lack of priority given by the agricultural
sector to the control of animal health problems unrelated
to livestock species and poor awareness as to effective and
ethically acceptable strategies to deal with dog-mediated
health issues. This lack of priority is partially due to
misconceptions about whose responsibility rabies control is.
Veterinary services may usually handle dog-related problems
in extreme situations (e.g., to “clean up” areas ahead of
specific events, respond to complaints by the public about
nuisance caused by “stray” dogs, including bites, or respond
to major rabies outbreaks), usually through indiscriminate
catch-and-kill operations. These operations are unpopular
at the local and international level and counterproductive in
the short and long terms. In addition, national and/or local
organizations promoting animal welfare and responsible pet
ownership, often supported by international animal welfare
organizations (e.g., WSPA, Humane Society International,
International Fund for Animal Welfare, etc.), are becoming
more influential in an increasing number of poorly resourced
countries. In many instances, these nongovernmental orga-
nizations will oppose catch- and-kill municipality actions, on
ethical grounds and also on the basis of lack of effectiveness
of these approaches, using evidence-based recommendations
of humane alternatives [12, 60].
In any plan for rabies prevention and control, there
is a need to bring all disparate partners (national human
health and animal health services, municipality services,
nongovernmental organizations, etc.) together in a collegial,
rather than adversarial fashion. In addition, there is a need
to provide support for veterinary services to carry out
annual or biannual mass dog vaccination campaigns for the
multiple years required to eliminate dog rabies, particularly
given other priorities relating to livestock production. As
demonstrated in many Latin American countries, and in
Bali and some Indian states, where the leading role in rabies
control is assumed by the public health sector and local,
national, and international animal welfare organizations,
respectively, the additional intersectoral support provided to
veterinary services can greatly improve dog rabies control
program design, implementation, and sustainability [59].
5.3. Human Prophylaxis. Rabies impact is mostly borne by
bite victims and the health care system. In many countries
the public health sector is often the first to advocate for dog
rabies control, as it is usually responsible for the financial
burden, in terms of health care and biologics costs. This
sector has to assume responsibility for human rabies deaths
following exposures to rabid animals when control strategies
in the animal reservoir are not effectively implemented
and when PEP is not administered correctly. In addition,
the government and the Ministry of Health should supply
necessary care and biologics to prevent the occurrence of
rabies. Provision of vaccines and RIG needed to prevent
rabies deaths is estimated theoretically to be around 200
PEP/100,000 inhabitants (based on figures from a range of
poorly resourced countries) [78], although this is likely to
vary depending on the setting. While rabies vaccine costs
remain in the range of other public health program expenses
supported by national health services in several countries,
in the absence of international funding these resources are
usually beyond the capacity of most impoverished countries.
These life-saving products are absolutely necessary and for
obvious ethical reasons the considerable sums required to
acquire them cannot be diverted from their emergency use.
However, improvements in the long-term cost effectiveness
of human rabies prevention will only be achieved by focusing
on control of rabies in its animal reservoir. Yet, funds
initially required to acquire human biologics cannot be
diverted to another sector to help increase its capacity to
establish effective animal rabies control programs [52, 54,
79, 80]. Any country willing to embark in rabies control
initiatives must realize that additional investment will be
required in all sectors, and that savings, particularly through
reduced demand for PEP, will only occur after several years
of implementation. Therefore, it is essential in this initial
investment phase that resources can be mobilized among
all sectors for human rabies prevention and canine rabies
elimination.
Concerning human prophylaxis, an additional challenge
is the lack of or limited availability and accessibility of human
biologics for PEP, a reoccurring problem in many poorly
resourced countries. These products should be provided free
or at a subsidized price by the health care system, but in
many places they are sold by government-owned and private
clinics at a cost, which is often beyond the financial means of
animal bite victims. The full cost of PEP alone (direct costs
of vaccine and RIG range between $40 to $75, depending on
country and product used [18]) as well as additional costs
(medical fees, transportation to hospital, accommodation,
and income loss) can easily represent several months of a
rural family revenue [18, 29]. Rabies biologics costs have
been decreasing gradually mostly due to a more competitive
market, with new vaccines and RIG being produced by
manufacturers based in emerging economies (particularly
in India and China). Although only a small number of
vaccines are currently prequalified by WHO, more emerging
products should fulfill WHO requirements and obtain this
recognition, increasing market competition and further
reducing costs. However, any increase in the availability of
additional products must be balanced against the risk of
biologics having poor quality [81] or counterfeit origins by
greater regulatory scrutiny. To assist dog-bite victims and
governments struggling to provide adequate quantities of
rabies biologics locally, WHO has been promoting the use of
the intradermal route for PEP, which provides a reduction
by 60 to 80% of the vaccine needed for one PEP regimen
[82]. Adoption of the intradermal route should be further
encouraged [83]. Furthermore, research on new products,
especially cocktails of monoclonal antibodies [84] to replace
human and equine RIG, improved vaccines, reduced PEP
regimens, and intradermal delivery devices should be a
priority [59].
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6. Conclusions
Eradication of a disease (e.g., rabies) brings the greatest
health benefit, which is the absence of the health threat.
It is also the quintessential example of health equity, as all
mankind reaps the benefits, leading to eternal cost savings.
Rabies is undoubtedly the most feared zoonosis in the world,
and takes a heavy toll on underprivileged communities living
in the poorest countries. The expertise to reduce the global
burden of rabies has been built, and significant strides have
been made scientifically and practically towards eliminating
canine rabies and reducing human rabies deaths in the
industrialized world.Moreover, considerablemilestones have
been achieved towards taking this progress to the next level,
by reducing the dramatic impact of rabies on human and ani-
mal communities in endemic areas of the developing world.
In an effort to enact a “One Health” approach towards global
rabies elimination, the creation of effective partnerships has
focused on coordinating research and operational activities
related to canine rabies elimination. A global rabies network,
covering over 150 countries, and uniting stakeholders from
the spectrum of veterinary, public health, pharmaceutical,
animal welfare, and wildlife conservation agencies, as well as
local communities, has been established. Strategies and tools
to successfully prevent and control rabies have been formu-
lated to assist rabies-affected areas in management efforts.
Operational activities have been implemented in a diversity
of Asian, African, and Latin American settings to create
replicable and sustainable models, acting as exemplary show-
cases for others. More broadly, current strategies towards
rabies elimination have the potential to be used as a mod-
ern example of integrated, evidence-driven, research-based
approaches applicable to other major zoonotic pathogens
affecting global health. While access to tools and knowledge
has been increased, providing all countries with the potential
to eliminate rabies from their territories, the ultimate
achievement of this goal, which would lead to health equity,
continues to face many challenges. Political and financial
constraints remain, highlighting the need for further action
towards building the political will to eliminate rabies and
to create sustainable and economic solutions, to develop
additional practical research tools, and to attract long-term
national and international funding support.
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